The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
What Is Breakthrough Therapy Designation?
Read More
post
Writing a Complex IND: The Top 3 Challenges and How to Avoid Them
Read More
post
Performing CMC Due Diligence for Molecule Licensing and Acquisitions
Read More
post
Why Protocol Amendments Matter: A Clinical Regulatory Medical Writing Perspective
Read More
Let's move from science to success.
Let’s Talk